Pulmonx Corporation (LUNG)
NASDAQ: LUNG · IEX Real-Time Price · USD
7.25
-0.05 (-0.68%)
May 31, 2024, 4:00 PM EDT - Market closed
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $281.41 million as of May 31, 2024. Its market cap has decreased by -39.14% in one year.
Market Cap
281.41M
Enterprise Value
205.62M
1-Year Change
-39.14%
Ranking
Category
Stock Price
$7.25
Market Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $616.87M to $281.41M, a decrease of -54.38%. That is a compound annual growth rate of -19.27%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2024 | 281.40M | -0.71% |
May 30, 2024 | 283.40M | -3.04% |
May 29, 2024 | 292.30M | -5.98% |
May 28, 2024 | 310.90M | -0.73% |
May 24, 2024 | 313.20M | -3.72% |
May 23, 2024 | 325.30M | -6.36% |
May 22, 2024 | 347.40M | 1.94% |
May 21, 2024 | 340.80M | -1.56% |
May 20, 2024 | 346.20M | -0.89% |
May 17, 2024 | 349.30M | -0.57% |
May 16, 2024 | 351.30M | -2.90% |
May 15, 2024 | 361.80M | 4.63% |
May 14, 2024 | 345.80M | 1.59% |
May 13, 2024 | 340.40M | 4.29% |
May 10, 2024 | 326.40M | -3.89% |
May 9, 2024 | 339.60M | -0.70% |
May 8, 2024 | 342.00M | -7.54% |
May 7, 2024 | 369.90M | 2.69% |
May 6, 2024 | 360.20M | -5.51% |
May 3, 2024 | 381.20M | 5.45% |
May 2, 2024 | 361.50M | 21.51% |
May 1, 2024 | 297.50M | 1.43% |
Apr 30, 2024 | 293.30M | 1.49% |
Apr 29, 2024 | 289.00M | 2.99% |
Apr 26, 2024 | 280.60M | -0.25% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Poseida Therapeutics | 289.90M |
CorMedix | 289.64M |
Viemed Healthcare | 287.66M |
Sera Prognostics | 285.17M |
Mersana Therapeutics | 285.10M |
Rani Therapeutics Holdings | 277.31M |
Black Diamond Therapeutics | 268.89M |
Cybin | 265.89M |